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Osteoporosis is a global epidemic, characterised by low bone
1
mass and altered micro-architecture of the bone. The population at risk of fractures due to fragile bones is expected to
increase by over two-folds by the year 2040; and the burden
rises with ageing populations.2 The situation is, especially,
alarming in the Asia-Paciﬁc region, where the population over
65 years is expected to quadruple by 2050, with over half of
the hip fractures in the world predicted to occur in the Asia-Pa3
ciﬁc by that year.
The Asia-Paciﬁc Consortium on Osteoporosis (APCO) was
launched in May 2019. Its vision is to reduce the burden of
osteoporosis and its associated complication of fractures in
the Asia- Paciﬁc. APCO is comprised of 39 experts in osteo4
porosis from 19 countries and regions. APCO determined that
the existing clinical guidelines for osteoporosis in countries in
the Asia- Paciﬁc were too varied in scope and recommendations, through a comprehensive and comparative review. In
addition, there are many low- and middle-income countries
(LMICs) where no guidelines exist.
The ﬁrst APCO’s project was, therefore, to formulate
harmonised pan Asia-Paciﬁc clinical practice standards (The
Framework) for the screening, diagnosis, and management of
osteoporosis. A ‘5IQ’ approach identiﬁcation, investigation,
information, intervention, integration and quality, was
employed to identify key elements in the various national and
regional guidelines for consideration to be included as standards of care. APCO members then shaped The Framework by
reaching a consensus using the Delphi technique through
5
multiple rounds of structured questionnaires.
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The Framework is a guidance document, proposing minimum
practice standards for osteoporosis management, focusing on
a broad range of high-risk groups, including patients who
already have had a fragility fracture, patients who are at a
higher risk according to country-speciﬁc fracture intervention
threshold and other high-risk groups, such as patients living
with conditions/or are on medications that predispose to bone
loss. An aspirational and readily measurable guidance, it is
hoped that the clinical guidelines on osteoporosis in the
various countries of the Asia-Paciﬁc will be benchmarked
against the scope and standards of care proposed in the framework.
In Pakistan, accurate data on osteoporosis is absent due to
limited number of epidemiological studies. Available studies
report lack of DEXA machines availability with a high burden of
osteoporosis on heel ultrasound scanning. Clinical guidelines
are non-existent; and there is no available report of
compliance to any action plan in clinical practice throughout
Pakistan.6
However, prevalence and associated complications of osteoporosis are expected to rise due to an aging population, a
sedentary lifestyle and urbanisation. The International Osteoporosis Foundation (IOF) reports that as of 2012, 9.91 million
people in Pakistan have osteoporosis, and this is estimated to
increase to 11.3 million in 2020 and to 12.91 million by 2050.7
Despite its common occurrence and availability of advanced
diagnostic and treatment modalities, there is lack of optimum
utilisation of resources, investigation and treatment. Deﬁnite
epidemiological data in the country is lacking and risk factors
such as multi-parity, longer life span after menopause, low
dietary calcium intake, vitamin D deﬁciency, and physical inactivity are on a perpetual rise. Diﬀerent local studies have
reported the frequency of osteoporosis from 5.6 to 17.8% in
pre-menopausal and 20-49.3% in postmenopausal women.6
Since the diagnosis and treatment of osteoporosis lies at an
intersection of multiple clinical specialties (endocrinology, rheumatology, orthopedic surgery, pathology, family medicine,
etc.), the management is not methodical, and the disease often
gets overlooked or mismanaged owing to a lack of responsibility
assertion by any medical specialty. There is an acute need to
take steps to develop guidelines for diagnosis, treatment and
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prevention of osteoporosis, dissemination of the resulting guidelines to the physicians across the country, and for inclusion of
osteoporosis as a priority in the National Action Plan by the
Government of Pakistan.
The way forward for Pakistan is to develop country-speciﬁc
national guidelines using the clinical standards in the APCO
Framework as a benchmark. Implementation of the clinical practice guidelines, thus developed, is expected to enable implementation of programmes for prevention and treatment of
osteoporotic fractures, fracture liaison services (FLS) for prevention of secondary fracture prevention (SFP) and provincial and
national fragility fracture networks. Real epidemiological data,
produced through registries, will enable identiﬁcation of knowledge gaps, and drive multi-sector action focusing on the preventive and management aspects of osteoporosis throughout
Pakistan.
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